5-ברומו-6,2-די-(lh-פיראזול-l-יל)פירימידין-4-אמין לשימוש בטיפול בסרטן

• 收藏
• 分享

专利权人:

NOVARTIS AG;PALOBIOFARMA S.L.

发明人:

申请号：

IL25735018

公开号：

IL257350D0

申请日:

2018.02.04

申请国别(地区):

IL

年份:

2018

代理人:

摘要：

To provide new therapies for the treatment of cancer with a low survival rate, represented by non-small cell lung cancer (NSCLC).SOLUTION: A combination product comprises a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof, and one or more immunotherapeutic agents selected from the group consisting of an anti-CTLA4 antibody, an anti-PD-1 antibody and an anti-PD-L1 antibody.SELECTED DRAWING: None

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/